Stock Track | ICU Medical Soars 6.75% Intraday on Earnings Beat and Analyst Price Target Increase

Stock Track
Feb 20

ICU Medical's stock soared 6.75% intraday on Friday, following the release of its quarterly earnings report that exceeded analyst expectations.

The company reported adjusted earnings of $1.91 per share for the quarter ended December 31, beating the mean analyst estimate of $1.69 per share. Although revenue fell 13.8% year-over-year to $535.94 million, it still surpassed the expected $530.63 million.

Concurrently, KeyBanc analyst raised the firm's price target on ICU Medical to $180 from $175 while maintaining an Overweight rating. Other analysts also maintained positive ratings, with the current average analyst rating being "buy" and a median 12-month price target of $180, representing significant potential upside from recent levels.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10